Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Infection and Immunity|July 26, 2021
Plasmodium Preerythrocytic Vaccine Antigens Enhance Sterile Protection in Mice Induced by Circumsporozoite ProteinShaji Daniel, Alexander Pichugin, Holly Torano, et al.
Malaria Journal|June 5, 2014
Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studiesJittawadee R Murphy, Walter R Weiss, David Fryauff, et al.
NPJ Vaccines|August 15, 2017
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infectionPrakash Srinivasan, G Christian Baldeviano, Kazutoyo Miura, et al.
Plos One|December 10, 2016
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060Charlotte V Hobbs, Erin E Gabriel, Portia Kamthunzi, et al.
Vaccines|June 27, 2025
SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus MacaquesPuthupparampil V Scaria, Christopher G Rowe, Ivan Kosik, et al.
Nature Medicine|February 23, 2021
Malaria is a cause of iron deficiency in African childrenJohn Muthii Muriuki, Alexander J Mentzer, Ruth Mitchell, et al.
The Journal of Clinical Investigation|February 9, 2021
Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not miceSara A Healy, Charles Anderson, Bruce J Swihart, et al.
Plos One|October 18, 2016
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve AdultsKawsar R Talaat, Ruth D Ellis, Janet Hurd, et al.
Frontiers in Immunology|August 22, 2022
Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West AfricaJohn Woodford, Issaka Sagara, Halimatou Diawara, et al.
NPJ Vaccines|April 15, 2023
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticlesNicholas J MacDonald, Kavita Singh, Karine Reiter, et al.
Pageof 24